LBJ Family Wealth Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,604
| Closed | -$2.61M | – | 24 |
|
|
2023
Q2 | $2.61M | Sell |
25,604
-4,303
| -14% | -$407K | 1.81% | 11 |
|
|
2023
Q1 | $2.72M | Sell |
29,907
-452
| -1% | -$26.5K | 1.91% | 11 |
|
|
2022
Q4 | $1.15M | Hold |
30,359
| – | – | 0.86% | 13 |
|
|
2022
Q3 | $763K | Hold |
30,359
| – | – | 0.62% | 16 |
|
|
2022
Q2 | $923K | Hold |
30,359
| – | – | 0.69% | 15 |
|
|
2022
Q1 | $999K | Hold |
30,359
| – | – | 0.64% | 15 |
|
|
2021
Q4 | $801K | Hold |
30,359
| – | – | 0.47% | 16 |
|
|
2021
Q3 | $3.05M | Hold |
30,359
| – | – | 1.82% | 11 |
|
|
2021
Q2 | $4.3M | Sell |
30,359
-9
| -0% | -$1.02K | 2.55% | 10 |
|
|
2021
Q1 | $3.03M | Hold |
30,368
| – | – | 1.91% | 11 |
|
|
2020
Q4 | $3.75M | Hold |
30,368
| – | – | 2.44% | 10 |
|
|
2020
Q3 | $2.96M | Hold |
30,368
| – | – | 2.24% | 10 |
|
|
2020
Q2 | $4.74M | Hold |
30,368
| – | – | 3.8% | 10 |
|
|
2020
Q1 | $4.38M | Sell |
30,368
-13,728
| -31% | -$2.65M | 4.24% | 9 |
|
|
2019
Q4 | $9.45M | Hold |
44,096
| – | – | 6.54% | 6 |
|
|
2019
Q3 | $3.54M | Hold |
44,096
| – | – | 2.66% | 10 |
|
|
2019
Q2 | $3.71M | Sell |
44,096
-9,308
| -17% | -$804K | 2.74% | 10 |
|
|
2019
Q1 | $4.56M | Hold |
53,404
| – | – | 2.57% | 10 |
|
|
2018
Q4 | $3M | Sell |
53,404
-7,371
| -12% | -$450K | 2.63% | 10 |
|
|
2018
Q3 | $4.97M | Sell |
60,775
-29,425
| -33% | -$2.07M | 3.81% | 9 |
|
|
2018
Q2 | $3.15M | Hold |
90,200
| – | – | 2.54% | 10 |
|
|
2018
Q1 | $1.85M | Hold |
90,200
| – | – | 1.53% | 12 |
|
|
2017
Q4 | $2.25M | Hold |
90,200
| – | – | 1.85% | 12 |
|
|
2017
Q3 | $2.81M | Hold |
90,200
| – | – | 2.39% | 11 |
|
|
2017
Q2 | $2.85M | Hold |
90,200
| – | – | 2.58% | 10 |
|
|
2017
Q1 | $2.04M | Hold |
90,200
| – | – | 1.94% | 13 |
|
|
2016
Q4 | $1.97M | Buy |
+90,200
| New | +$2.28M | 1.96% | 13 |
|
Other funds holding RETA
LBJ Family Wealth Advisors's RETA Position: Q3 2023 in Review
LBJ Family Wealth Advisors sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 25,604 shares — an estimated $2.61M sold.
LBJ Family Wealth Advisors first reported a position in RETA in Q4 2016 and held it in 27 quarters. The position peaked at $9.45M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- LBJ Family Wealth Advisors reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- LBJ Family Wealth Advisors sold 25,604 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.61M.
- LBJ Family Wealth Advisors first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2016 and held it in 27 quarters.
- LBJ Family Wealth Advisors's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $9.45M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on LBJ Family Wealth Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.